# GHK-Cu Research Doses, Routes, and Half-Life in the Literature | GHK-Cu

> GHK-Cu research doses by species and route: in vitro collagen synthesis at 10^-9 M, topical 0.05-2%, rodent IP and intranasal protocols. No validated human pharmacokinetic half-life exists.

The concentrations and routes documented in the literature, by species and model, with the pharmacokinetic gaps named. Not a dosing guide.

## Concentrations and routes in the research record

GHK-Cu research doses span a wide range because the molecule is studied in cell culture, rodents, and topical human formulations, each with its own units. This section describes what was administered to which model — not a recommendation for use in people. GHK-Cu is a research peptide; injectable and systemic protocols circulated in community contexts have no peer-reviewed human pharmacokinetic basis.

In human fibroblast cultures, collagen-synthesis effects appear at 10^-12 to 10^-9 M, peaking near 10^-9 M [1]. Topical cosmetic and clinical formulations run roughly 0.05% to 2% (w/w) in creams, serums, and gels [3]. Rodent systemic studies used intraperitoneal dosing for pulmonary and fibrosis models and intranasal dosing for cognitive models, across microgram-per-gram to milligram-per-kilogram ranges. The human hair-loss RCT applied a 5-ALA + GHK topical at 50-100 mg/mL [4].

## Half-life and pharmacokinetics

No rigorous human pharmacokinetic half-life has been published for GHK-Cu. The free tripeptide (340.38 Da) is rapidly cleared by plasma peptidases; a rat HPLC study documented rapid metabolism of GHK to the dipeptide histidyl-lysine (HK) after intravenous dosing [12]. Secondary literature cites a short systemic elimination half-life on the order of 1-2 hours, with the copper-chelated complex being more stable than free GHK.

Topical application behaves differently. Rather than clearing quickly, GHK-Cu forms a dermal copper depot: in a human skin-penetration study, copper applied as the tripeptide permeated dermatomed skin with about 97 ug/cm^2 retained as a depot over 48 hours [5]. That local reservoir, not a systemic half-life, is what governs topical availability.

## Routes studied, by model

The route matters as much as the dose, because GHK-Cu behaves differently depending on how it is delivered. Topical is the dominant human route, used in creams, serums, liposomes, microemulsions, wound dressings, and nanofiber systems, and the one with the deepest record [3][7][11]. Rodent systemic studies have used intraperitoneal delivery for pulmonary and fibrosis models, intranasal delivery for cognitive models, oral gavage for colitis, and intravenous or subcutaneous dosing for pharmacokinetic work [12]. Biomaterial-bound delivery — peptide conjugated to alginate, coated onto scaffolds, embedded in hydrogels — is a distinct research route in which the concentration is set by the material rather than a free dose [7][8][10].

This breadth is exactly why a single 'dose' is meaningless out of context: 10^-9 M at a fibroblast [1], 1 mM as a scaffold coating [10], and 50-100 mg/mL on a scalp [4] are all 'GHK-Cu doses' in completely different systems. The site presents them as model-specific facts, not a ladder anyone should climb.

## Stability and formulation in the research

The GHK-Cu complex has a very high copper stability constant (log K around 16.4), far higher than free GHK, which limits pro-oxidant free-copper release. It is most stable near pH 5-6.5 at a 1:1 copper-to-peptide ratio; the blue-violet color of a reconstituted solution is the expected Cu(II) absorption and indicates an intact complex, whereas brown or green shifts indicate oxidation or precipitation. Strong reducing agents — ascorbic acid below about pH 3.5 — reduce Cu(II) and break the complex, and AHAs and BHAs can destabilize it or compete for copper [3].

Because free GHK is highly hydrophilic (clogP -2.24), passive skin penetration is limited [14]. Research delivery strategies to improve it include palmitoylation (Pal-GHK, clogP about 1.14), liposomal encapsulation [11], ionic-liquid microemulsions, and microneedle pretreatment [14].

---

A greenhouse of the GHK-Cu copper-peptide literature read at golden hour — every collagen figure, hair-count delta, and gene-expression number grown straight from its source, the gaps left in plain light, and nothing here cultivated for sale.